64 results
8-K
GYRE
Gyre Therapeutics Inc
14 Feb 24
Results of Operations and Financial Condition
5:16pm
of China (“Shanghai Genomics”), the Minority Holders (as defined therein) and Continent Pharmaceuticals Inc., a Cayman Islands company limited by shares
8-K/A
EX-99.1
67fq4tprsxl3
12 Jan 24
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
58ytdlxcp2ak9l yv
12 Jan 24
Completion of Acquisition or Disposition of Assets
4:01pm
424B3
dsy9gtpsdcdtn9p
1 Nov 23
Prospectus supplement
5:18pm
8-K
4t70g12 f4k
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
424B3
dysty yv0
27 Oct 23
Prospectus supplement
5:10pm
8-K
dybyho
31 Aug 23
Entry into a Material Definitive Agreement
4:17pm
8-K
fxjnvjn5
14 Aug 23
Results of Operations and Financial Condition
6:01am
8-K
EX-99.1
vi640l7yijm8
14 Aug 23
Results of Operations and Financial Condition
6:01am